OBJECTIVE: To investigate parameters of energy metabolism during a 28 d VLCD to identify possible prognostic markers of weight change observed, subsequently, when the subjects were on a six-month hypocaloric diet. DESIGN: Longitudinal, clinical intervention study of a 2 MJ diet daily for 28 d and six month follow-up under a conventional, hypocaloric diet. SUBJECTS: Seven pre-menopausal women and one male all morbidly obese but otherwise healthy (age: 16±47 y, BMI 38.9±50.5 kg/m 2 ). MEASUREMENTS: Body weight, resting energy expenditure (REE), resting respiratory quotient (RQ) and the 5 h thermic effect of food (TEF) were assessed by indirect calorimetry at the beginning and at the end of a 28 d VLCD treatment. Body composition was measured on day 1 by hydrodensitometry and tetrapolar bioelectrical impedance (TBIA), on day 28 by TBIA and nitrogen balance (NB) and by TBIA on follow-up. RESULTS: The individual weight loss during VLCD (mean 9.9 AE 2.4 kg) was signi®cant (P`0.01) and correlated signi®cantly with energy de®cit (r 0.83, P 0.01). REE/FFM decreased 6.2% (FFM TBIA ) and 8.9% (FFM NB ), respectively. TEF 28 was unchanged from TEF 1 while fasting RQ declined during the intervention period but was back to baseline already within one month of follow-up even though the mean weight loss at six months had increased to 14.0 AE 5.6 kg. There was a signi®cant (P`0.05) positive correlation between RQ 28 and body-weight changes after one, three and six months of follow-up. The RQ 28 explained 60±72% of the inter-individual variation in weight change. CONCLUSION: The resting RQ measurement is recommended as a simple and inexpensive assessment at the end of a strict weight-loss regimen in order to identify those individuals who may need greater assistance in maintaining a weight-loss when placed on a subsequent, free-living hypocaloric diet.
Introduction
A low relative resting energy expenditure (REE) is considered one of the genetically determined factors responsible for weight gain. 1±4 In contrast, the high relative REE observed in obese subjects probably results from an adaptational mechanism attempting to minimize additional increase in body weight. 5 On the other hand, the energy-metabolism adaptation observed during caloric restriction for rapid weight loss could predispose the obese patient to a return to weight gain. 6, 7 This hypothesis has been addressed in a few studies but with contradictory results.
8±10
With respect to the respiratory quotient in obesity, a lower capability of fatty acid oxidation correlates positively with long-term weight gain 11 but, when the obese state is reached, subjects show an increased fat/carbohydrate oxidation ratio which may be an attempt to pre-empt a continued expansion of their fat stores. 12 Nevertheless, weight-loss has the effect of increasing a previously-low RQ 13 thus placing the previously-obese subjects at a higher risk of storing energy as fat and, consequently, of regaining weight.
One of the favoured treatments for the morbidly obese patient is the prescription of a liquid formula very-low-calorie diet (VLCD) under metabolic-ward conditions. 1415 However, essential obesity being a multi-factorial and heterogeneous disorder, 16 not all obese patients have a similar long-term response. 15 Hence, the aim of this study was to attempt to identify some metabolic variables that may be prognostic of medium-to long-term success of treatment.
Subjects and methods

Subjects
We studied seven pre-menopausal women and one man selected from among those attending the obesity clinic. All of them were morbidly obese (BMI b 35 kg/m 2 ) without diabetes mellitus, impaired glucose tolerance, 17 bulimia nervosa 18 or any primary or secondary metabolic disease. The subjects were hospitalised on the metabolic ward for 28 d. During the previous three months all of the subjects had been attending the obesity clinic every month and claimed to have been following our prescribed hypocaloric diet. Body weights had remained stable (AE0.4 kg) which suggest an equilibrium in energy balance. The study protocol was approved by the Ethics Committee of the Hospital St. Joan and each subject gave voluntary, fully-informed, written consent to participation in the study.
Study design
On hospitalisation, all the subjects were prescribed a VLCD. On day 1, prior to VLCD administration, and on day 28, body composition by TBIA and the measurements of REE and TEF were performed. Body composition was also assessed by hydrostatic weighing on day 1. Nitrogen balance during hospitalisation was used to determine changes in FFM. On months one, three and six after discharge from hospital, body composition and REE were assessed by TBIA and indirect calorimetry, respectively.
Very-low-calorie diet
All subjects received a commercial VLCD liquid preparation (Modifast R , Wander SA, Bern, Switzerland) containing approximately 52 g protein, 46 g carbohydrate, 6.5 g fat (46%:41%:13% percentage energy, respectively). Energy administered by this formula was 1915 KJ/d (458 Kcal/d). The formula also contained electrolytes, trace elements and vitamins in accordance with the Recommended Dietary Allowances. 19 The diet was provided in three isocaloric aliquots (breakfast, lunch and dinner) on each of the 28 d of the study. Subjects were also allowed to drink non-energy-containing¯uids ad libitum.
Energy expenditure measurements
Energy Expenditure (EE) was assessed using opencircuit indirect calorimetry (Deltatrac R Datex, Helsinki, Finland), which includes a differential paramagnetic O 2 sensor and an infrared CO 2 analyser. Exhaled air was collected using a canopy. Before each test, O 2 and CO 2 sensors were calibrated using gas mixtures of precisely-known O 2 and CO 2 concentrations. The precision of the RQ (de®ned as the quotient between VCO 2 and VO 2 ) and¯ow measurements were con®rmed periodically by the ethanol combustion test. 20 The mean error of RQ and¯ow determinations were 1% and 1.75% respectively. The within-individual mean standard deviation for day-to-day replicate measurements of REE, in our laboratory, is 164 KJ which corresponds to a coef®cient of variation of analysis of 2.3%.
Resting energy expenditure. After an overnight (12 h) fast, VO 2 and VCO 2 were continuously measured for 60 min on basal conditions. Taking the ®rst 30 min as an equilibration period for both, subject and equipment, REE was calculated using Weir's equation from the last 30 min period of measurement. 21 Thermic effect of food. On days 1 and 28 of the hospitalisation period and after a 12 h fast, energy expenditure was measured over a 5 h period following the ingestion of a test-meal containing the energy equivalent of 1/3 of the individual's REE which had been measured on the same day. The test-meal was in the form of a liquid formula (Pentadrink R , Nutrition laboratories, Zoetermeer, Holland) and contained 6.3 KJ/ml (13% of energy derived from protein, 39% from fat, and 48% from carbohydrate).
Postprandial Energy Expenditure (PEE) was calculated by the trapezoidal area method (the increments in the area under the curves of VO 2 and VCO 2 measurements) and expressed in KJ/min, using Weir's equation for fasting and post-absorptive states. 21 The Thermic Effect of Food (TEF) was calculated as PEE area (KJ/5 h) 7 (REE (KJ/ min) 6 300 min) and expressed in KJ/min or as a percentage increment over the previously-determined REE.
Body-composition measurements
Height was measured to the nearest 1 mm using a wall-mounted stadiometer (Hotain, Crosswell, Wales, UK). Weight was measured to an accuracy of 100 g on days 1 and 28 and at months one, three, and six of follow-up.
Hydrodensitometry. Whole-body density was measured on day 1 using an hydrostatic weighing system as we have described elsewhere. 7 Due to technical reasons beyond our control, this measurement had not been repeated, for some individuals, on day 28 and, hence, these incomplete data have not been included in the statistical analyses.
The measurements were conducted under fasting conditions after the morning's voiding. Body density was calculated as follows:
Where wt is weight in air, UWW is underwater weight, RV is residual lung volume measured with the helium-dilution technique, 22 and GIV is gastrointestinal volume (assumed to be 100 ml). All values used were corrected for the density of water at ambient temperature and pressure.
Body fat was calculated using the revised equation of Brozek et al. 23 A value for FFM (FFM D ) was obtained by subtracting fat mass from total body weight in air.
Tetrapolar bioelectrical impedance analysis (TBIA). Whole-body impedance was measured under fasting conditions using a tetrapolar bioelectrical impedance system (Human-Im Scan R , Dietosystem, Spain), as we have described elsewhere. 7 Fat-Free Mass (FFM TBIA ) was calculated using the VLCDs and subsequent body weight loss S Valtuen Äa et al equations validated for obese males and females by Segal et al 24 on days 1, 4 and 28 of the VLCD period and months one, three, and six of follow-up.
The mean day-to-day coef®cient of variation for within-patient impedance measurements in our laboratory is 0.71%. On all occasions, the observed impedance deviated from the expected value bỳ 3.5 O.
Nitrogen balance measurements. For all patients during hospitalisation, 24 h urine samples were collected and analysed daily for nitrogen content using the Kjeldahl technique. 25 Nitrogen losses via the skin were taken as 5 mg N/kg/d. 26 Menstrual nitrogen losses were assumed, at the upper range (90± 100 mL) of menses volume, as 0.1 g N loss/d. 27 Nitrogen losses due to nitrates formation and faecal nitrogen were taken as 0.1 g N/d and 0.003 g N/kg/d respectively. 26 FFM calculated from nitrogen balance (FFM NB ) on day 28 was the result of subtracting cumulative nitrogen balance from FFM D on day 1, assuming 1 g of nitrogen to be 6.25 g of body protein or 31.25 g of fat-free mass.
Pattern of physical activity
During hospitalisation, subjects followed a 60 minper-day physical activity program consisting of walking on a treadmill and cycling on an ergometer. The duration and the intensity of the moderate exercise were controlled by a physiotherapist. For the rest of the day the patients were allowed to continue their sedentery activities, such as reading or watching television. The physical activity program was stopped at least 48 h before the Energy Expenditure (EE) measurements performed on day 28 of VLCD.
Moderately hypocaloric follow-up diet
After the VLCD period and just before discharge from hospital, the subjects were instructed by a dietitian to follow a balanced diet (15% of energy as protein, 30% as fat, and 55% as carbohydrate) based on interchangeable foodstuffs. The energy content of the diet for each subject was equivalent to the individual's REE measured on day 28 so as to facilitate a sustained weight-loss. During the follow-up period, subjects attended the obesity clinic monthly for weight assessment and advice regarding alternative food-item replacement to encourage dietary compliance. The subjects were advised to maintain an equivalent level of physical exercise as when hospitalised.
Statistical analyses
Statistical analyses were performed using the SPSS/ PC package.
Results
Body weight and body composition
Subjects' physical characteristics on admission are shown in Table 1 .
Mean weight loss during the 28 d of VLCD was 9.9 AE 2.4 kg or 8.4% of the initial body weight (P`0.01). As expected, the weight loss in kg correlated signi®cantly with the degree of energy restriction (de®ned as the initial REE minus the energy content of VLCD) for each individual (r 0.83, P 0.01). The mean maximal weight reduction, relative to the beginning of the study, was observed in the third month of follow-up (14.2 AE 4.1 kg, P`0.05). Up to the sixth month, mean weight loss was still greater than that observed at the end of the hospitalisation period (14.0 AE 5.6 kg) although the difference between these two values was not signi®cant ( Table 2) . 28 From day 1 to day 28, REE showed a drop of 8.9% and 6.2% from that predicted using FFM NB and FFM TBIA , respectively (P`0.05). No other signi®cant differences between predicted and observed REE were found during the VLCD period or the follow-up (Table 3) .
Thermic effect of food
The average energy content of the meal administered for the test on day 28 was 282 KJ lower than that provided on day 1 (2298 AE 332 KJ and 2579 AE 407 KJ, respectively; P`0.05) as it represented 1/3 of the previously-determined REE caloric value. As expected, the 5 h-PEE measured on day 1 (5.90 AE 0.88 KJ/min) was signi®cantly higher than that measured on day 28 (5.28 AE 0.79 KJ/min) of VLCD (P`0.05). However, no signi®cant differences were observed between the two days with respect to the TEF, expressed either in KJ/min (0.54 AE 0.17 vs 0.42 AE 0.13) or as a percentage increment over the same day (10.2 AE 3.6% vs 8.9 AE 1.7%). Table 3 shows the mean values of RQ measured during hospitalisation and follow-up. In all measurements performed during the administration of VLCD, RQ was signi®cantly lower than that determined on day 1. No signi®cant differences in RQ were observed between admission and months one, three and six of follow-up.
Respiratory quotient
Prognostic factors of weight-loss regain
In order to identify the metabolic and/or body composition factors predictive of weight changes, linear regression analyses were performed between body weight changes in months one, three and six relative to day 28 and the following variables: Of all the variables considered above, only resting RQ 28 correlated signi®cantly with weight changes during the follow-up expressed either in kg (r 0.77, P`0.05 at month 1; r 0.85, P`0.01 at month 3; and r 0.78, P`0.05 at month 6) or as percentage of body weight on day 28 (r 0.67, NS at month one; r 0.75, P`0.05 at months three and six). The RQ 28 alone explained 60±72% of the interindividual weight-change variation (Figure 1) . However, the RQ 28 could be an indirect re¯ection of an individual's prior short-term energy imbalance. In order to assess if this factor had a signi®cant contribution to the inter-individual variation observed in RQ 28 , we considered: (a) body weight loss during hospitalisation and (b) the individual energy de®cit during VLCD (expressed either as the difference between initial REE and the 1915 KJ diet administered daily or as the energy administered as a percentage of the initial REE) as independent variables in a stepwise multiple regression analysis. None of these variables explained a signi®cant percentage of the inter-individual variability associated with the RQ assessed at the end of the VLCD period.
Discussion
VLCDs have been widely used to ensure a rapid, signi®cant weight loss in very obese patients and, also, to investigate energy-metabolism regulation. Despite con¯icting results, the general consensus is Signi®cantly different from day 1 (Wilcoxon test): * P`0.008; ** P`0.02; *** P`0.03. Signi®cantly different from day 28 (Wilcoxon-test): { P`0.02; { P`0.05.
that, during severe energy restriction, REE decreases beyond the predictable effects of body composition changes. 7 However, controversy exists regarding the existence of a long-term metabolic adaptation (understood as a drop in REE larger than that predicted from changes in FFM) when energy balance is almost restored. 9, 10, 29 In our study, REE decreased between 6% and 9% more than that would have been predicted from changes in FFM on the 28 d period of VLCD. However, these signi®cant differences between observed and predicted REE no longer persisted at month 1 of Signi®cantly different from the observed REE, { P`0.05. Figure 1 Scatterplots of the respiratory quotient assessed on day 28 (RQ 28 ) vs weight change on follow-up relative to weight at the time of discharge from hospital.
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VLCDs and subsequent body weight loss S Valtuen Äa et al the follow-up, despite the mean weight loss during VLCD being maintained. This suggests that the reduction in REE observed during the VLCD could be explained, mainly, by the decrease in FFM in conjunction with the restriction of energy intake. Therefore, the well-documented long-term lack of success of VLCD treatment cannot be adequately explained on the basis of a persistent metabolic adaptation to severe energy restriction resulting in decreased at-rest body-function requirements. It is of note that not all the obese subjects had equivalent responses to the VLCD. As can be observed in Figure 2 , while one group of individuals showed a considerable decrease in REE per FFM during the VLCD treatment others experienced a stabilisation or even an increase of this ratio, relative to the baseline. Whether these differences in metabolic response to dietary restriction play a role in the subsequent maintenance of weight-loss needs to be investigated, perhaps with a more diverse group of study subjects and/or a greater number of individuals.
Although the contribution of TEF to total EE is considerably smaller than that of REE, a thermogenic defect has been proposed as being involved in the pathogenesis of obesity as well as in the relapse after massive weight loss. 30 In the present study, 5 h-TEF was measured in patients (with normal glucose tolerance) after the ingestion of a mixed meal and, there being no signi®cant change in the TEF values pre-and post-VLCD, would indicate that a 9 kg loss of weight does not materially affect the cost of nutrient processing.
Hence, from an energy-metabolism point of view, two hypotheses may be considered with respect to the high susceptibility of obese individuals to weightregain:
(a) a reduction of activity level post-hospitalisation and/or a decrease in the energy cost of this activity resulting from a reduced body weight 31 (b) an impaired capacity to adapt their food intake to their energy requirements when a change from accustomed body weight takes place.
However, a more speci®c approach to explain the marked predisposition of obese people to weight regain may be required. In a longitudinal study in Pima Indians, Zurlo et al 11 observed that a low 24 h-RQ was a risk factor for subsequent weight gain and other, cross-sectional, studies have convincingly demonstrated that obese subjects consume a more fat-rich diet than normal-weight subjects. Surprisingly, however, the role played by a low rate of carbohydrate/fat oxidation in the maintenance of body weight in obese subjects subsequent to weight reduction has been poorly explored. Froidevoix et al 32 reported that changes in body weight after a VLCD treatment could be partially explained by net changes in basal RQ measured during follow-up. The changes in follow-up RQ in relation to the changes in body weight over the same period were measured after 7± 20 week of carbohydrate re-feeding following the VLCD regimen. These simultaneous measurements have little or no predictive value.
In the present study, the resting RQ measured on the last day of the 28 d VLCD period correlated signi®cantly with subsequent body-weight changes, 61% of the variance at month six of follow-up being explained by this variable. This suggests that, under severe energy restriction, a low rate of fat/carbohydrate oxidation could be a predictive factor of subsequent weight regain since a higher predisposition to fat imbalance would lead to expanded boy fat stores and to increased body weight. Hence, resting RQ being a simple and inexpensive measurement, its determination at the end of a VLCD treatment could be a useful clinical tool to identify those patients who appear to loose less weight on a subsequent hypocaloric diet and so may require further additional therapies to assist in the maintenance of the weight loss achieved during VLCD.
Conclusions
In summary, three aspects are of note: (a) no signi®cant differences between the observed REE and that predicted from FFM during follow-up were found. This suggests that the metabolic adaptation to energy restriction observed the end of the VLCD period has little medium-to long-term effect on subsequent body-weight change; (b) a body weight loss of 9 kg does not signi®cantly affect the 5 h TEF of a mixed diet, and (c) the 30 min resting RQ measured on the last day of a 28 d VLCD could partially predict additional weight loss in the following six months.
